The medical community is buzzing by retatrutide, a novel dual GIP and GLP-1 receptor that’s showing remarkable results in early research. This treatment works by replicating natural hormones to regulate appetite and promote feelings of satiety, ultimately leading noticeable weight decrease. While still under review and not yet available, initial